Increased full-year 2026 revenue guidance by $2 billion to a range of $82 billion to $85 billion, reflecting sustained ...

Eli Lilly & Company (LLY) is a global pharmaceutical powerhouse that has redefined modern medicine through its leadership in ...

Eli Lilly on Thursday reported first-quarter earnings and revenue that blew past estimates and hiked its full-year sales ...

Eli Lilly (NYSE: LLY) is currently the leader in the weight loss market. Sales of the company's anti-obesity medicine, ...

What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 4.3% in the morning session after the ...

Foundayo became available on April 9 and has already reached 20,000 patients as Eli Lilly builds its marketing machine for ...

Amylin drugs have become the next big thing in obesity. Eli Lilly CEO David Ricks, understandably, thinks his rivals don’t ...

After just a few weeks on the market, thousands are already on Foundayo, Eli Lilly's oral weight loss pill. The drugmaker is ...

A strong performance from Mounjaro overseas boosted Lilly’s results, and the company raised its guidance for the year for ...

Eli Lilly (LLY) stock jumps as the company raised its full-year outlook alongside better-than-expected Q1 2026 financials ...